SURGALIGN HOLDINGS, INC.

Delisted

CIK 1760173fmd_1DDW8KT6WXGYB8PWWEJHJ0BZAYManufacturing · Orthopedic, Prosthetic & Surgical Appliances & SuppliesTemplate: Standard

Coverage: Jan 02, 2016 to Mar 31, 2023, 29 periods

Income Statement · Annual · Millions · USD
Line item	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022
Total revenues	276	90	92	117	102	91	82
Cost of revenue	143	36	34	33	44	30	42
Gross profit	133	54	59	85	58	61	40
Research and development	16	13	14	17	12	14	16
Selling, general and administrative	117	91	98	135	124	–	–
Total operating expenses	149	117	123	328	256	202	120
Operating income	(15)	(63)	(65)	(243)	(198)	(137)	(78)
Interest expense	2	3	3	13	–	0	1
Interest and investment income	0	0	0	0	0	–	–
Other non-operating income (expense)	(2)	0	0	0	0	13	23
Income before taxes	(17)	(63)	(65)	(243)	(198)	(124)	(56)
Income tax expense	(3)	(18)	(15)	6	(3)	(1)	(1)
Net income from continuing operations	(14)	(44)	(50)	(249)	(194)	(123)	(55)
Net income	(14)	7	(3)	(212)	(34)	(85)	(55)
Net income to common shareholders	(17)	3	(5)	(212)	(34)	–	–